July 09, 2021 at 08:21PM Questions and Answers Regarding the End of the Compliance and Enforcement Policy for Certain Human Cells, Tissues, or Cellular or Tissue-based Products (HCT/Ps)

This is the CBER HCT/Ps Q&As- End of Compliance and Enforcement Policy main page with information for health care providers, clinics and regulated industry need to know about the end of FDA's compliance and enforcement policy, which ended on May 31, 2021 if they offer certain HCT/Ps.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2TY4eOy